Clinical Trial Update: Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating renzapride for constipation-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Renzapride (renzapride)

Snippet

Sponsor: Alizyme | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED